Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Cancer Research|September 2, 2008
Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoidsRoberta Venè, Patrizia Larghero, Giuseppe Arena, et al.Nature Reviews. Clinical Oncology|August 2, 2012
Cancer prevention by targeting angiogenesisAdriana Albini, Francesca Tosetti, Vincent W Li, et al.Thrombosis and Haemostasis|September 6, 2006
Identification of a new truncated form and deamidation products of fibrinopeptide B released by thrombin from human fibrinogenBarbara Cardinali, Gianluca Damonte, Luca Melone, et al.Cancer Letters|April 29, 2017
The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancerAntonella Brizzolara, Roberto Benelli, Roberta Venè, et al.Frontiers in Immunology|May 28, 2019
Human Gut-Associated Natural Killer Cells in Health and DiseaseAlessandro Poggi, Roberto Benelli, Roberta Venè, et al.Molecular Pharmacology|February 28, 2003
N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell deathFrancesca Tosetti, Roberta Venè, Giuseppe Arena, et al.Chemmedchem|August 14, 2018
Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging ProbesCaterina Camodeca, Elisa Nuti, Francesca Tosetti, et al.International Journal of Cancer|July 29, 2008
The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidantsJenny Ceccarelli, Laura Delfino, Emanuela Zappia, et al.Journal for Immunotherapy of Cancer|December 21, 2022
Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximabRoberto Benelli, Delfina Costa, Laura Salvini, et al.Molecular Cancer Therapeutics|January 24, 2007
Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implicationsRoberta Venè, Giuseppe Arena, Alessandro Poggi, et al.Pageof 4